Latest Daily News

Latest News

January 12, 2017

Drs. Geoffrey Y. Ku and David H. Ilson discuss recent phase III studies that have attempted to refine the role of perioperative strategies in the treatment of gastric cancer.

Read more

January 12, 2017

As the worldwide death rate from hepatobiliary cancers continues to grow, Drs. Karasic and Loaiza-Bonilla explain that research must focus on finding an effective treatment—and immunotherapy could be the answer. 

Read more

January 12, 2017

Dr. Jorge Gallardo and colleagues discuss the epidemiology of esophageal, gastric, liver, gallbladder, pancreatic, colon, and rectal cancers in Chile and how the country’s changing demographics across the past 20 years have increased cancer mortality rates.

Read more
January 12, 2017

How does the location of colon cancer tumors impact clinical decisions?

Read more
January 12, 2017

Drs. Mariela Blum Murphy and Jaffer A. Ajani discuss the latest research on immune checkpoint inhibitors for advanced gastroesophageal cancers.

Read more
January 12, 2017

Dr. Philip highlights several recent and ongoing studies in the field of pancreatic cancer and identifies the biggest hurdles that research must overcome.

Read more

January 12, 2017

Dr. Nina J. Karlin discusses why she continues to attend the GI Cancers Symposium, as well as her advice for first-time attendees.

Read more

January 12, 2017

Drs. Jonathan A. Nowak and Shuji Ogino answer a question about whether it is possible to use molecular assays to distinguishing between hyperplastic polyps and sessile serrated polyps.

Read more
January 12, 2017

Experts discuss the initial data from the RESORCE trial, which explored the second-line use of regorafenib in patients with advanced hepatocellular carcinoma.

Read more

January 12, 2017

Dr. Charles R. Thomas Jr. discusses why he continues to attend the Gastrointestinal Cancers Symposium and what he hopes to take away from this year’s meeting.

Read more

January 12, 2017

Drs. Daniela Molena and Hans Gerdes answer a question posed by an attendee during a Best of ASCO® Meeting about treatment of short-segment Barrett esophagus with high-grade dysplasia.

Read more

January 12, 2017

Dr. Roderich E. Schwarz has attended 13 Gastrointestinal Cancers Symposia. He discusses why it is important for surgeons to attend this meeting.

Read more

January 12, 2017

Drs. Manisha Palta, Christopher Willett, and Brian Czito discuss the current data on stereotactic body radiotherapy for the treatment of HCC and future research directions.

Read more
January 12, 2017

Drs. Sunnie S. Kim and Waddah B. Al-Refaie answer a question about the optimal timing for surgery after neoadjuvant chemotherapy in advanced gastric cancer.

Read more

January 12, 2017

Drs. Young and Chau review several early-phase studies on combination immunotherapy treatments for GI cancers and what these studies have uncovered about the certain tumor types that are responsive and those that are poorly immunogenic. 

Read more
January 12, 2017

Dr. Florian Lordick outlines the evolving classification of gastric cancer and discusses recent studies on emerging treatment options. 

Read more
January 12, 2017

Drs. Kit Man Wong and William M. Grady discuss genomic tools and large-scale collaborative efforts that have led to significant advances in our understanding of the common molecular features of CRC.

Read more

January 23, 2016

Drs. Kabir Mody (pictured) and Tushar Patel discuss recent advances in our understanding of the genomics of cholangiocarcinoma that offer new opportunities for more effective approaches to systemic therapies and could improve outcomes for patients with these cancers.

Read more

January 23, 2016

Dr. Robert S. Sandler questions the usefulness and benefits of colonoscopy in elderly patients, arguing the risks might outweigh the benefits. He advises that doctors should discuss with patients whether or not to continue screening after age 75 or if life expectancy is limited. 

Read more